Dataset Information


The shortcut strategy for beta thalassemia prevention.

ABSTRACT: We propose antenatal blood tests using high-resolution DNA melting (HRM) analysis for beta thalassemia mutation detection after hemoglobin A2 estimation as a modified strategy for the identification of beta thalassemia at-risk couples. Antenatal blood samples of 1,115 couples were transferred from the antenatal care clinic. Hemoglobin A2 was quantified, and proportions ?3.5% were further assessed for beta thalassemia mutation using HRM analysis. Twelve types of beta thalassemia mutations, including hemoglobin E, were identified. There were 23 couples who were detected as at-risk. All at-risk couples were identified within 7 working days after sample receipt. Prenatal diagnosis revealed 6 affected fetuses. One fetus was homozygous CD17 (AT), and five fetuses exhibited beta0 - thalassemia/hemoglobin E disease. These results were consistent with the outcomes calculated using the Hardy-Weinberg equation. Antenatal blood tests for mutation detection using high-resolution DNA melting analysis after hemoglobin A2 estimation is a feasible laboratory method for the recruitment of couples with a fetus that is at risk for beta thalassemia. This modified strategy is cost-effective and may be beneficial for use in a beta thalassemia prevention program.

SUBMITTER: Suwannakhon N 

PROVIDER: S-EPMC6036980 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5751541 | BioStudies
2014-01-01 | S-EPMC4121066 | BioStudies
2020-01-01 | S-EPMC6961315 | BioStudies
2010-01-01 | S-EPMC2942774 | BioStudies
2018-01-01 | S-EPMC6816879 | BioStudies
1000-01-01 | S-EPMC6016721 | BioStudies
2020-01-01 | S-EPMC7049201 | BioStudies
2012-01-01 | S-EPMC3517603 | BioStudies
2019-01-01 | S-EPMC6395345 | BioStudies
2019-01-01 | S-EPMC6565566 | BioStudies